跳至主要内容
临床试验/ISRCTN14335124
ISRCTN14335124已完成未知

mHealth Biometrics for Type 2 Diabetes (MOTIVATE T2D)

iverpool John Moores University0 个研究点目标入组 125 人开始时间: 2020年10月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
125

研究概览

简要总结

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34836904/ (added 29/11/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Clinical Diagnosis of T2D within the previous 5–24 months
  • 2. Aged 40 - 75 years
  • 3. Treating diabetes with only Metformin or lifestyle modifications (diet and exercise)
  • 4. For those prescribed Metformin: Stable dose for 3-months or more

排除标准

  • 1. HbA1c >10% (>86mmol/mol)
  • 2. Blood pressure >160/100 mmHg
  • 3. Prescription of oral antidiabetic drug other than Metformin
  • 4. Prescription of Insulin
  • 5. Unstable angina
  • 6. Myocardial infarction within the previous 3 months
  • 7. Transient ischemic attack (TIA) in the previous 6 months
  • 8. Heart failure >= class 2
  • 9. Inability to increase level of activity
  • 10. Pregnancy or planning to become pregnant
  • 11. <6 months postpartum or stopped breastfeeding <1 month before recruitment
  • 12. Not owning a smartphone/ or having no data plan or access to WiFi
  • 13. Currently meeting the recommended exercise guidelines (150 min of moderate intensity exercise per week)

研究者

发起方
iverpool John Moores University

相似试验